PriceTargets.com logo

Third Harmonic Bio - THRD Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $5.00
  • Forecasted Upside: -7.06%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$5.38 As of 12/4/2025 01:00 AM ET
+0 (0.00%)
Get New Third Harmonic Bio Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for THRD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for THRD

Analyst Price Target is $5.00
▼ -7.06% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for Third Harmonic Bio in the last 3 months. The average price target is $5.00, with a high forecast of $5.00 and a low forecast of $5.00. The average price target represents a -7.06% upside from the last price of $5.38.

This chart shows the closing price for THRD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 3 contributing investment analysts is to hold stock in Third Harmonic Bio. This rating has held steady since February 2025, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/13/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/11/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/10/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
3/10/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
6/8/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
9/6/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
11/5/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
12/5/2025

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/28/2025Stifel NicolausReiterated RatingBuy ➝ Hold$23.00 ➝ $5.00
2/12/2025Morgan StanleyDowngradeOverweight ➝ Equal Weight$20.00 ➝ $5.00
2/11/2025Raymond James FinancialReiterated RatingOutperform ➝ Market Perform
8/9/2024Morgan StanleyUpgradeEqual Weight ➝ Overweight$12.00 ➝ $20.00
6/18/2024Stifel NicolausInitiated CoverageBuy$23.00
6/7/2024Raymond James FinancialInitiated CoverageOutperform$18.00
8/11/2023Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$5.00 ➝ $7.00
12/16/2022Jefferies Financial GroupDowngradeBuy ➝ Hold$30.00 ➝ $3.60
12/15/2022Lifesci CapitalDowngradeOutperform ➝ Market Perform
12/15/2022Morgan StanleyDowngradeOverweight ➝ Equal Weight$34.00 ➝ $5.00
10/10/2022Lifesci CapitalReiterated RatingOutperform
10/10/2022Jefferies Financial GroupInitiated CoverageBuy$30.00
10/10/2022CowenInitiated CoverageOutperform
10/10/2022CowenInitiated CoverageOutperform
10/10/2022Morgan StanleyInitiated CoverageOverweight$34.00
(Data available from 12/5/2020 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/9/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/8/2025
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/8/2025
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/7/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/6/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/6/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/5/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/5/2025

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Third Harmonic Bio logo
TF Financial Corporation is a savings and loan holding company. The Company's direct and indirect subsidiaries include Third Federal Bank (the Bank), Teragon Financial Corporation, Penns Trail Development Corporation and Third Delaware Corporation. The Bank is a community oriented Pennsylvania stock savings bank offering a variety of financial services to meet the needs of the communities it serves. As of December 31, 2011 the Bank operated fourteen branch offices in Bucks and Philadelphia Counties, Pennsylvania and in Mercer County, New Jersey. During the year ended December 31, 2011, the Company's subsidiary, TF Investments Corporation merged into TF Financial Corporation. In July 2013, the Company acquired Roebling Financial Corp, Inc. (Roebling) and its wholly-owned subsidiary, Roebling Bank.
Read More

Today's Range

Now: $5.38
Low: $5.38
High: $5.38

50 Day Range

MA: N/A

52 Week Range

Now: $5.38

Volume

N/A

Average Volume

247,013 shs

Market Capitalization

$242.80 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.12

Frequently Asked Questions

What sell-side analysts currently cover shares of Third Harmonic Bio?

The following Wall Street research analysts have issued reports on Third Harmonic Bio in the last twelve months: Morgan Stanley, Raymond James Financial, Inc., and Stifel Nicolaus.
View the latest analyst ratings for THRD.

What is the current price target for Third Harmonic Bio?

0 Wall Street analysts have set twelve-month price targets for Third Harmonic Bio in the last year. Their average twelve-month price target is $5.00, suggesting a possible downside of 7.1%. Stifel Nicolaus has the highest price target set, predicting THRD will reach $5.00 in the next twelve months. Stifel Nicolaus has the lowest price target set, forecasting a price of $5.00 for Third Harmonic Bio in the next year.
View the latest price targets for THRD.

What is the current consensus analyst rating for Third Harmonic Bio?

Third Harmonic Bio currently has 3 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in THRD, but not buy more shares or sell existing shares.
View the latest ratings for THRD.

What other companies compete with Third Harmonic Bio?

Other companies that are similar to Third Harmonic Bio include MoonLake Immunotherapeutics, Rapt Therapeutics, Erasca, Vir Biotechnology and Rezolute. Learn More about companies similar to Third Harmonic Bio.

How do I contact Third Harmonic Bio's investor relations team?

Third Harmonic Bio's physical mailing address is 3 Penns Trail, NEWTOWN, PA 18940, United States. The company's listed phone number is +1-215-5794000 and its investor relations email address is [email protected]. The official website for Third Harmonic Bio is www.thirdfedbank.com. Learn More about contacing Third Harmonic Bio investor relations.